Context Therapeutics Inc (CNTX)
1.41
-0.09
(-6.00%)
USD |
NASDAQ |
Nov 22, 09:41
Context Therapeutics Total Assets (Quarterly): 86.33M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 86.33M |
| June 30, 2024 | 102.71M |
| March 31, 2024 | 11.05M |
| December 31, 2023 | 16.06M |
| September 30, 2023 | 22.99M |
| June 30, 2023 | 27.76M |
| March 31, 2023 | 31.97M |
| December 31, 2022 | 37.97M |
| Date | Value |
|---|---|
| September 30, 2022 | 42.08M |
| June 30, 2022 | 44.70M |
| March 31, 2022 | 47.03M |
| December 31, 2021 | 51.31M |
| September 30, 2021 | 2.259M |
| June 30, 2021 | 2.719M |
| March 31, 2021 | 2.252M |
| December 31, 2020 | 0.4673M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.4673M
Minimum
Dec 2020
102.71M
Maximum
Jun 2024
33.10M
Average
29.86M
Median
Total Assets (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 1.635B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.472M |
| Shareholders Equity (Quarterly) | 83.86M |